Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 11;22(1):125.
doi: 10.1186/s12934-023-02134-x.

Calcium-assisted sortase A cleavage of SUMOylated metallothionein constructs leads to high-yield production of human MT3

Affiliations

Calcium-assisted sortase A cleavage of SUMOylated metallothionein constructs leads to high-yield production of human MT3

Avinash Kumar Singh et al. Microb Cell Fact. .

Abstract

Background: Mammalian metallothioneins (MTs) are small (6-7 kDa), intracellular, cysteine-rich, metal-binding proteins involved, inter alia, in the homeostasis of zinc and copper, detoxification of heavy metals, antioxidation against reactive oxygen species, and protection against DNA damage. The high cysteine content (~ 30%) in MTs makes them toxic to bacterial cells during protein production, resulting in low yield. To address this issue, we present for the first time a combinatorial approach using the small ubiquitin-like modifier (SUMO) and/or sortase as fusion tags for high-level expression of human MT3 in E. coli and its purification by three different strategies.

Results: Three different plasmids were generated using SUMO, sortase A pentamutant (eSrtA), and sortase recognition motif (LPETG) as removable fusion tags for high-level expression and purification of human MT3 from the bacterial system. In the first strategy, SUMOylated MT3 was expressed and purified using Ulp1-mediated cleavage. In the second strategy, SUMOylated MT3 with a sortase recognition motif at the N-terminus of MT3 was expressed and purified using sortase-mediated cleavage. In the final strategy, the fusion protein His6-SUMO-eSrtA-LPETG-MT3 was expressed and purified by one-step sortase-mediated inducible on-bead autocleavage. Using these three strategies the apo-MT3 was purified in a yield of 11.5, 11, and 10.8 mg/L, respectively, which is the highest yield achieved for MT expression and purification to date. No effect of MT3 on Ni2+-containing resin was observed.

Conclusion: The SUMO/sortase-based strategy used as the production system for MT3 resulted in a very high expression level and protein production yield. The apo-MT3 purified by this strategy contained an additional glycine residue and had similar metal binding properties as WT-MT3. This SUMO-sortase fusion system is a simple, robust, and inexpensive one-step purification approach for various MTs as well as other toxic proteins with very high yield via immobilized metal affinity chromatography (IMAC).

Keywords: IMAC; Metallothionein; Plasmid generation; Protein purification; Recombinant expression; SUMO; Sortase; Ulp1.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Schematic representation of sortase-mediated purification of SUMOylated human MT3. Purified SUMO-LPETG-MT3 fusion protein was incubated with eSrtA for 4 h at 37 °C in the presence of 5 mM CaCl2 for sortase-mediated cleavage of MT3 from the fusion protein. The cleaved G-MT3 was then purified from the reaction mixture using Ni2+-IMAC purification
Fig. 2
Fig. 2
Schematic representation of Ca2+-inducible on-bead autocleavage purification of G-MT3 from SUMOylated human MT3. The fusion protein His6-SUMO-eSrtA-LPETG-MT3 was immobilized/bound on Ni2+-NTA beads. On-bead sortase-mediated autocleavage was induced by incubating the beads in 5 mM CaCl2 for 4 h at 37 °C. Purified G-MT3 was collected in the flow-through
Fig. 3
Fig. 3
Plasmid map of the constructed expression vectors encoding fusion proteins SUMO-LPETG-MT3 and sSrtA-MT3
Fig. 4
Fig. 4
Purification of fusion proteins. A SDS-PAGE purification profile of SUMO-MT3 and SUMO-LPETG-MT3. Lane 1 = lysate, Lane 2 = supernatant, Lane 3 = flow-through, Lane 4 = wash, Lane 5 = first elution, Lane 6 = second elution, Lane 7 = protein ladder, Lane 8 = second elution, Lane 9 = first elution, Lane 10 = wash, Lane 11 = flow-through, Lane 12 = supernatant, Lane 13 = lysate. B SDS-PAGE purification profile of eSrtA-MT3. Lane 1 = lysate, Lane 2 = supernatant, Lane 3 = flow-through, Lane 4 = wash, Lane 5 = first elution, Lane 6 = second elution, Lane 7 = protein ladder, Lane 8 = protein ladder Bio-Rad. C SDS-PAGE profile of purified fusion proteins. Lane 1 = SUMO-MT3, Lane 2 = SUMO-LPETG-MT3, Lane 3 = protein ladder, Lane 4 = eSrtA-MT3. D SDS-PAGE profile of eSrtA mediated cleavage of SUMO-LPETG-MT3. Lane 1 = fusion protein SUMO-LPETG-MT3, Lane 2 = eSrtA cleaved MT3, Lane 3 = SUMO eluted from beads after cleavage, Lane 4 = proteins from beads, Lane 5 = fusion protein in eSrtA buffer, Lane 6 = empty, and lane 7 = protein ladder Bio-Rad. E Comparison of total protein yield (mg/L) obtained using various purification systems. MT3-WT stands for protein obtained from the IMPACT system
Fig. 5
Fig. 5
UV–vis monitored Cd2+ titration of (A) 1 µM metal-free G-MT3, GS-MT3, and MT3-WT in 50 mM borate pH 7.4, 100 mM NaClO4, 100 µM TCEP. Panel (B) indicates saturation isotherms recorded at 240 nm for CdSO4 titrations. Red vertical lines indicate metal-to-protein ratios where absorbance reaches saturation with Cd2+

Similar articles

Cited by

References

    1. Krȩżel A, Maret W. The Bioinorganic chemistry of mammalian metallothioneins. Chem Rev. 2021;121:14594–14648. doi: 10.1021/acs.chemrev.1c00371. - DOI - PubMed
    1. Margoshes M, Vallee BL. Cadmium protein from equine kidney cortex. J Am Chem Soc. 1957;79:4813–4814. doi: 10.1021/ja01574a064. - DOI
    1. Klaassen CD, Liu J, Diwan BA. Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol. 2009;238:215–220. doi: 10.1016/j.taap.2009.03.026. - DOI - PMC - PubMed
    1. Kägi JH, Kojima Y. Chemistry and biochemistry of metallothionein. Experientia Suppl. 1987;52:25–61. doi: 10.1007/978-3-0348-6784-9_3. - DOI - PubMed
    1. Nordberg M, Nordberg GF. Toxicological aspects of metallothionein. Cell Mol Biol. 2000;46:451–463. - PubMed